Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Clinical profile of children with haemophilia at the University Hospital of Brazzaville

View through CrossRef
Abstract Introduction Haemophilia is a rare hereditary haemorrhagic disease caused by coagulation factor VIII (haemophilia A) or IX (haemophilia B) deficiency. Very few data exist on this disease in Congo. This survey aims to describe the epidemiological and clinical aspects of the children affected. Materials and methods A descriptive cross-sectional study was carried out in the haematology department of the Brazzaville University Hospital over a period of two years. Children (under 18 years of age) with haemophilia and with a factor VIII or IX level less than or equal to 30% were identified. The parameters analysed included age, diagnostic delay, type and severity of haemophilia, type and frequency of bleeding manifestations, complications and history of transfusion. Results Nineteen patients were identified with an average age at diagnosis of four years. The average time to diagnosis was six years, and the most frequent first known bleeding episode was haemorrhage during circumcision. Family history was found in 14 cases. There were 13 cases of haemophilia A and six cases of haemophilia B. Fourteen cases were severe haemophilia; no mild cases were identified. Haemorrhagic manifestations included haemarthrosis, haematomas and mucocutaneous haemorrhages. The average number of haemorrhagic episodes per year was 12. Haemophilic arthropathy was present at diagnosis in seven cases, with the main location being the knee. The average number of hospitalisations before diagnosis was two. Sixteen patients had been transfused at least once. Conclusion Although circumcision is the most frequent first known haemorrhagic manifestation of haemophilia in Congo, patients are often diagnosed late, sometimes with severe osteoarticular complications. Further measures are needed to help ensure early diagnosis and improve care.
Title: Clinical profile of children with haemophilia at the University Hospital of Brazzaville
Description:
Abstract Introduction Haemophilia is a rare hereditary haemorrhagic disease caused by coagulation factor VIII (haemophilia A) or IX (haemophilia B) deficiency.
Very few data exist on this disease in Congo.
This survey aims to describe the epidemiological and clinical aspects of the children affected.
Materials and methods A descriptive cross-sectional study was carried out in the haematology department of the Brazzaville University Hospital over a period of two years.
Children (under 18 years of age) with haemophilia and with a factor VIII or IX level less than or equal to 30% were identified.
The parameters analysed included age, diagnostic delay, type and severity of haemophilia, type and frequency of bleeding manifestations, complications and history of transfusion.
Results Nineteen patients were identified with an average age at diagnosis of four years.
The average time to diagnosis was six years, and the most frequent first known bleeding episode was haemorrhage during circumcision.
Family history was found in 14 cases.
There were 13 cases of haemophilia A and six cases of haemophilia B.
Fourteen cases were severe haemophilia; no mild cases were identified.
Haemorrhagic manifestations included haemarthrosis, haematomas and mucocutaneous haemorrhages.
The average number of haemorrhagic episodes per year was 12.
Haemophilic arthropathy was present at diagnosis in seven cases, with the main location being the knee.
The average number of hospitalisations before diagnosis was two.
Sixteen patients had been transfused at least once.
Conclusion Although circumcision is the most frequent first known haemorrhagic manifestation of haemophilia in Congo, patients are often diagnosed late, sometimes with severe osteoarticular complications.
Further measures are needed to help ensure early diagnosis and improve care.

Related Results

Treatment trends for haemophilia A and haemophilia B in the United States: results from the 2010 practice patterns survey
Treatment trends for haemophilia A and haemophilia B in the United States: results from the 2010 practice patterns survey
Summary.  Frequent evaluation of haemophilia treatment is necessary to improve patient care. The 2010 Practice Patterns Survey (PPS) investigated current trends in haemophilia trea...
A preliminary application of a haemophilia value framework to emerging therapies in haemophilia
A preliminary application of a haemophilia value framework to emerging therapies in haemophilia
AbstractIntroductionEmergence of new therapies are anticipated to improve clinical outcomes and quality of life of persons with haemophilia. Challenges in conducting randomized cli...
A transgender person with haemophilia
A transgender person with haemophilia
Abstract Introduction Transgender people face many obstacles to accessing healthcare but cultural changes are likely to i...
Dental considerations in a patient with haemophilia
Dental considerations in a patient with haemophilia
Abstract Haemophilia is a rare blood clotting disorder, characteristic features of which include extemporaneous and post-traumatic subcutaneous bleeding and mucos...
Haemophilia care in Iraq; a multi-centre study
Haemophilia care in Iraq; a multi-centre study
Objectives: To evaluate the level of care available to haemophilia patients. Method: The descriptive, retrospective analytical study was conducted from December 15, 2020, to March...
Normalisation of Haemostasis in Haemophilia A
Normalisation of Haemostasis in Haemophilia A
Haemophilia A (Factor VIII [FVIII] levels ≤40 IU/dL) is a chronic condition with consequences beyond bleeding complications. Many people with haemophilia A (PwHA) experience pain, ...

Back to Top